Table 3 Results of included studies (n = 11)

Adewuya et al. (2006) [25]

Nigeria

Validation study

182 pregnant women (32–36 weeks)

MINI

EPDS

Alvarado-Esquivel et al. (2014a) [36]

Mexico

Validation study

158 adult pregnant women (2-9 months)

DSM-IV

EPDS

Alvarado-Esquivel et al. (2014b) [37]

Mexico

Validation study

120 teenage pregnant women (3–9 months)

DSM-IV

EPDS

e Couto et al. (2015) [1]

Brazil

Validation study

247 pregnant women (2nd trimester)

MINI

EPDS

BDI

HAM-D

Fernandes et al. (2011) [4]

India

Cross sectional study

194 pregnant women (3rd trimester)

MINI

EPDS

K-10

Kaaya et al. (2002) [23]

Tanzania

Randomized controlled trial

903 HIV positive pregnant women (8–26 weeks)

SCID

HSCL-25

Martins et al. (2015) [39]

Brazil

Cross sectional study

807 adolescent pregnant women (2nd trimester)

MINI

EPDS

BDI

Natamba et al. (2014) [35]

Uganda

Cross sectional study

123 [36 HIV positive and 87 HIV negative pregnant women] (10–26 weeks)

MINI

CES-D-20

Rochat et al. (2013) [3]

South Africa

Cross sectional study

109 [49 HIV positive and 60 HIV negative pregnant women] (Second half of pregnancy)

SCID

EPDS

Spies et al. (2009) [22]

South Africa

Prospective study

129 pregnant women (<20 weeks)

SCID

K-10

Stewart et al. (2013) [34]

Malawi

Validation study

224 pregnant women (28–34 weeks)

SCID

EPDS

SRQ